(Q39506309)

12 September 2017

title

3,3'-Diindolylmethane inhibits breast cancer cell growth via miR-21-mediated Cdc25A degradation (English)

1 reference

12 September 2017

1 reference

1 reference

Yucui Jin

1

1 reference

12 September 2017

publication date

15 July 2011

1 reference

Molecular and Cellular Biochemistry

12 September 2017

published in

1 reference

12 September 2017

volume

358

1 reference

12 September 2017

issue

1-2

1 reference

12 September 2017

page(s)

345-354

1 reference

Global cancer statistics, 2002

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

Meta-analysis of studies on breast cancer risk and diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

Apple phytochemical extracts inhibit proliferation of estrogen-dependent and estrogen-independent human breast cancer cells through cell cycle modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

A critical review of the bioavailability of glucosinolates and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

Molecular targets and anticancer potential of indole-3-carbinol and its derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

Bcl-2 family-mediated apoptotic effects of 3,3'-diindolylmethane (DIM) in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

p53 activates the PANK1/miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

The nuclear envelope can control gene expression and cell cycle progression via miRNA regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

Solubilizing excipients in oral and injectable formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

Down-regulation of uPA and uPAR by 3,3'-diindolylmethane contributes to the inhibition of cell growth and migration of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

3,3'-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

Cdc25A promotes G2/M transition in oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

The when and wheres of CDC25 phosphatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

CDC25 phosphatases in cancer cells: key players? Good targets?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

A novel mechanism of indole-3-carbinol effects on breast carcinogenesis involves induction of Cdc25A degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

Toxic and chemopreventive ligands preferentially activate distinct aryl hydrocarbon receptor pathways: implications for cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

DIM stimulates IFNgamma gene expression in human breast cancer cells via the specific activation of JNK and p38 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

3,3'-Diindolylmethane is a novel mitochondrial H(+)-ATP synthase inhibitor that can induce p21(Cip1/Waf1) expression by induction of oxidative stress in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

Targeting of aryl hydrocarbon receptor-mediated activation of cyclooxygenase-2 expression by the indole-3-carbinol metabolite 3,3'-diindolylmethane in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

Requirement for p53 and p21 to sustain G2 arrest after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

p21-Mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

Role of the Cdc25A phosphatase in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

Regulation of human Cdc25A stability by Serine 75 phosphorylation is not sufficient to activate a S phase checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

The Chk2 tumor suppressor is not required for p53 responses in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0985-0

Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model.

21 January 2018

1 reference

12 December 2020

Indole-3-carbinol and prostate cancer

1 reference

12 December 2020

Overexpression of CDC25A associated with poor prognosis in breast cancer

1 reference

12 December 2020

Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro

1 reference

12 December 2020

MicroRNA-mediated gene silencing modulates the UV-induced DNA-damage response

1 reference

12 December 2020

10.1007/S11010-011-0985-0

Identifiers

DOI

1 reference

release_ck7vamixdfcxbn57belzkq5zva

12 September 2017

Fatcat ID

0 references

1 reference